Back to Journals » OncoTargets and Therapy » Volume 9

Review

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

       
Total article views   HTML views PDF downloads Totals
16,554 Dovepress* 7,880+ 1,367 9,247
PubMed Central* 8,674 1,017 9,691
Totals 16,554 2,384 18,938
*Since 9 February 2016
+Since July 2016

View citations on PubMed Central and Google Scholar